Theranos

Theranos founder Elizabeth Holmes is reportedly set to be transferred from prison to a halfway home next year, according to a Guardian report. Holmes is serving a sentence for fraud related to the blood-testing startup's collapse. The reported step toward release is drawing renewed attention to one of Silicon Valley's most notorious fraud cases.

Doctors are highlighting theranostics, an emerging approach to treating advanced prostate cancer that pairs diagnostic imaging with targeted therapy in a single process. The method allows physicians to detect cancer cells and deliver radiation treatment directly to them, potentially improving outcomes for patients whose disease no longer responds to standard therapies.